SUVEN LIFE SCIENCES Fact Sheet, SUVEN LIFE SCIENCES Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES Fact Sheet    (SVNP)


FREE TRANSCRIPT: See How Richa Picks Potentially Crorepati-Making Stocks...


Here is the latest financial fact sheet of SUVEN LIFE SCIENCES. For more details, see the SUVEN LIFE SCIENCES quarterly results and SUVEN LIFE SCIENCES share price and chart. For a sector overview, read our pharmaceuticals sector report.

SUVEN LIFE SCIENCES Price History

Price Rs 92.2
Mkt Cap Rs m 11,735
Vol '000 100.8
P/E X -10.3
P/CF X -17.3
EPS (TTM) Rs -8.9
1 Day % -2.1
No. of shares m 127.28
1 Week % -9.2
1 Month % 7.9
1 Year % 9.7
52 week H/L Rs 124.4/69.5
As on Jan 21, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SUVEN LIFE SCIENCES Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
SUVEN LIFE SCIENCES EQUITY SHARE DATA
High Rs229251338335109 
Low Rs1511551692019 
Sales per share (Unadj.) Rs42.649.122.41.11.1 
Earnings per share (Unadj.) Rs6.99.7-1.9-7.4-5.7 
Diluted earnings per shareRs6.89.7-1.9-7.4-5.7 
Cash flow per share (Unadj.) Rs8.511.7-0.8-7.1-5.3 
Dividends per share (Unadj.) Rs1.001.501.5000 
Adj. dividends per shareRs1.001.501.500.000.00 
Avg Dividend yield %0.50.70.600 
Book value per share (Unadj.) Rs52.460.318.811.35.6 
Adj. book value per shareRs52.460.318.811.35.6 
Shares outstanding (eoy) m127.28127.28127.28127.28127.28 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x4.54.111.3156.860.6 
Avg P/E ratio x27.720.9-135.0-24.0-11.3 
P/CF ratio (eoy) x22.217.4-332.4-25.1-12.0 
Price / Book Value ratio x3.63.413.515.811.5 
Dividend payout %14.615.4-79.900 
Avg Mkt Cap Rs m24,15825,82632,26922,6058,168 
No. of employees `000NANANANANA 
Total wages/salary Rs m522613365174185 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
SUVEN LIFE SCIENCES INCOME DATA
Net Sales Rs m5,4266,2532,857144135 
Other income Rs m21123327214078 
Total revenues Rs m5,6376,4853,129285212 
Gross profit Rs m1,2912,016-110-1,157-799 
Depreciation Rs m2142481424243 
Interest Rs m57461969 
Profit before tax Rs m1,2311,9552-1,064-775 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m359718241-122-53 
Profit after tax Rs m8721,237-239-942-722 
Gross profit margin %23.832.3-3.8-802.8-593.1 
Effective tax rate %29.236.715,423.111.46.9 
Net profit margin %16.119.8-8.4-653.6-535.3 
SUVEN LIFE SCIENCES BALANCE SHEET DATA
Current assets Rs m5,8126,7383,9821,5951,966 
Current liabilities Rs m2,0812,2581,5701,2001,098 
Net working cap to sales %68.871.784.5273.8643.8 
Current ratio x2.83.02.51.31.8 
Inventory Days Days2071732852,3122 
Debtors Days Days31363575477 
Net fixed assets Rs m3,2213,4962241,159257 
Share capital Rs m127127127127127 
"Free" reserves Rs m6,5437,5472,2641,306584 
Net worth Rs m6,6707,6742,3911,433711 
Long term debt Rs m2592218114 
Total assets Rs m9,03310,2344,2062,7552,223 
Interest coverage x22.743.21.1-192.1-81.3 
Debt to equity ratio x00000 
Sales to assets ratio x0.60.60.70.10.1 
Return on assets %10.312.5-5.2-34.0-32.0 
Return on equity %13.116.1-10.0-65.7-101.5 
Return on capital %18.626.00.9-73.3-107.1 
Exports to sales %91.181.0196.894.269.1 
Imports to sales %34.232.063.0877.5547.1 
Exports (fob) Rs m4,9435,0665,62213693 
Imports (cif) Rs m1,8572,0011,7991,265737 
Fx inflow Rs m4,9435,0665,62213693 
Fx outflow Rs m1,8572,0011,7991,265737 
Net fx Rs m3,0863,0653,822-1,129-644 
SUVEN LIFE SCIENCES CASH FLOW
From Operations Rs m 1,092 699 -526 -1,346 -960 
From Investments Rs m -3,106 -6 371 1,462 558 
From Financial Activity Rs m -304 -521 45 28 349 
Net Cashflow Rs m -2,319 173 -177 144 -53 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 60.0%
Institution 1.0%
Non-Institution 39.0%
Total 100.0%
Free Float 40.0%
Pledged promoter holdings 0.0%
Shareholding as on Dec 2021
 

Company Information

Regd Off 8-2-334 S D E Serene Chambers, 6th Floor Road No 5 Avenue 7, Banjara Hills, Hyderabad - 500034
E-mail info@suven.com Web www.suven.com
Tel +91-40- 23541142/3315/ 23543311 32921695 32921696 Fax +91-40- 23541152
Sector PHARMACEUTICALS Group Private sector
Tr Agent K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
Auditor Karvy & Company
COMP SEC: K. Hanumantha Rao YEAR OF INC: 1989 BSE CODE: 530239 FV (Rs): 1 DIV YIELD (%): -

Read: SUVEN LIFE SCIENCES 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    

Compare SUVEN LIFE SCIENCES With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    




Today's Market

Sensex Sheds 427 Points, Nifty Ends Near 17,600; Bajaj Finserv, Tata Steel & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Views on news

SUVEN LIFE SCIENCES 2020-21 Annual Report Analysis (Annual Result Update)

Nov 18, 2021 | Updated on Nov 18, 2021

Here's an analysis of the annual report of SUVEN LIFE SCIENCES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE SCIENCES. Also includes updates on the valuation of SUVEN LIFE SCIENCES.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

10 Indian Companies with the Fastest Growth in Dividend Payouts... (Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain (Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks (Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES - VISTA PHARMA COMPARISON

COMPARE SUVEN LIFE SCIENCES WITH

MARKET STATS